J2 Capital Management »

Abcellera Biologics shares owned by J2 Capital Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by J2 Capital Management from 13F filings

Historical chart of J2 Capital Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by J2 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by J2 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $41k 12k 3.42
2025-09-30 $62k 12k 5.03
2025-06-30 $45k 13k 3.43

More positions owned by J2 Capital Management

Ishares Tr TRS FLT RT BD (TFLO)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Northern Lts Fd Tr Iii Hcm Defen 500 (LGH)
Ishares Tr Core High Dv Etf (HDV)
Strategy Day Hagan Smart (SSUS)
Ishares Gold Tr Ishares New (IAU)
Pacer Fds Tr Trendp Us Mid Cp (PTMC)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Pacer Fds Tr Trendpilot Eur (PTEU)
Strategic Trust Running Gwth Etf (RUNN)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Val Etf (IWD)

View all positions for J2 Capital Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Ubs Global Asset Management Americas
Two Sigma Investments
Two Sigma Advisers
Goldman Sachs Group
Arrowpoint Asset Management
BlackRock
Millennium Management
Renaissance Technologies
Susquehanna International
UBS Group
Guardian Partners
Driehaus Capital Management
Jane Street

View all funds holding Abcellera Biologics